Evaluation of a minimally invasive glucose biosensor for continuous tissue monitoring

Analytical and Bioanalytical Chemistry

Volumn 408, Issue 29, 2016, Pages 8427-8435

  Sharma, Sanjiv ^a   Huang, Zhenyi ^a   Rogers, Michelle ^a   Boutelle, Martyn ^a   Cass, Anthony E G ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Continuous glucose monitoring (CGM); Electrochemical sensor; Microneedles

Indexed keywords

BIOSENSORS; ELECTROCHEMICAL SENSORS; ELECTRODES; GLUCOSE; GLUCOSE SENSORS; NEEDLES; PHOTORESISTS;

CONTINUOUS GLUCOSEMONITORING (CGM); CONTINUOUS MEASUREMENTS; CONTINUOUS MONITORING; GLUCOSE CONCENTRATION; HEALTHY VOLUNTEERS; MICRONEEDLES; NEGATIVE PHOTORESISTS; REFERENCE ELECTRODES;

GLUCOSE OXIDASE;

GLUCOSE; POLYMER;

CHEMISTRY; DEVICES; ELECTROCHEMISTRY; ELECTRODE; EQUIPMENT DESIGN; EXTRACELLULAR FLUID; GENETIC PROCEDURES; HUMAN; MICROINJECTION; NEEDLE; NORMAL HUMAN; PHYSIOLOGIC MONITORING; PROCEDURES; SKIN;

BIOSENSING TECHNIQUES; ELECTROCHEMISTRY; ELECTRODES; EQUIPMENT DESIGN; EXTRACELLULAR FLUID; GLUCOSE; HEALTHY VOLUNTEERS; HUMANS; MICROINJECTIONS; MONITORING, PHYSIOLOGIC; NEEDLES; POLYMERS; SKIN;

EID: 84995741153     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-016-9961-6     Document Type: Article

References (25)

1. Pickup JC, Freeman SC, Sutton AJ. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self-monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data. BMJ. 2011;343:d3805.
2. Battelino T, Phillip M, Bratina N, Nimri R, Oskarsson P, Bolinder J. Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care. 2011;34(4):795–800. doi:10.2337/dc10-1989.
3. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008;359(14):1464–76. doi:10.1056/NEJMoa08050174.
4. El-Laboudi A, Oliver NS, Cass A, Johnston D. Use of microneedle array devices for continuous glucose monitoring: a review. Diabetes Technol Ther. 2013;15(1):101–15. doi:10.1089/dia.2012.0188.
5. Miller KM, Xing D, Tamborlane WV, Bergenstal RM, Beck RW. Challenges and future directions of the T1D exchange clinic network and registry. J Diabetes Sci Technol. 2013;7(4):963–9.
6. Oliver NS, Toumazou C, Cass AEG, Johnston DG. Glucose sensors: a review of current and emerging technology. Diabet Med. 2009;26(3):197–210. doi:10.1111/j.1464-5491.2008.02642.x.
7. Mastrototaro J, Shin J, Marcus A, Sulur G. The accuracy and efficacy of real-time continuous glucose monitoring sensor in patients with type 1 diabetes. Diabetes Technol Ther. 2008;10(5):385–90. doi:10.1089/dia.2007.0291.
8. Keenan DB, Mastrototaro JJ, Zisser H, Cooper KA, Raghavendhar G, Lee SW, et al. Accuracy of the enlite 6-day glucose sensor with guardian and veo calibration algorithms. Diabetes Technol Ther. 2012;14(3):225–31. doi:10.1089/dia.2011.0199.
9. Moniz ARB, Michelakis K, Trzebinski J, Sharma S, Johnston DG, Oliver N, et al. Minimally invasive enzyme microprobes: an alternative approach for continuous glucose monitoring. J Diabetes Sci Technol. 2012;6(2):479–80.
10. Trzebinski J, Sharma S, Radomska-Botelho Moniz A, Michelakis K, Zhang Y, Cass AEG. Microfluidic device to investigate factors affecting performance in biosensors designed for transdermal applications. Lab Chip. 2012;12(2):348–52. doi:10.1039/c1lc20885c.
11. Donnelly RF, Singh TRR, Woolfson AD. Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety. Drug Deliv. 2010;17(4):187–207. doi:10.3109/10717541003667798.
12. Indermun S, Luttge R, Choonara YE, Kumar P, du Toit LC, Modi G, et al. Current advances in the fabrication of microneedles for transdermal delivery. J Control Release. 2014;185:130–8. doi:10.1016/j.jconrel.2014.04.052.
13. Larraneta E, McCrudden MTC, Courtenay AJ, Donnelly RF. Microneedles: a new frontier in nanomedicine delivery. Pharm Res. 2016;33(5):1055–73. doi:10.1007/s11095-016-1885-5.
14. Lee JW, Han MR, Park JH. Polymer microneedles for transdermal drug delivery. J Drug Target. 2013;21(3):211–23.
15. Narayan R, Goering P. Laser micro- and nanofabrication of biomaterials. MRS Bull. 2011;36(12):973–82.
16. Stevenson CL, Santini JT, Langer R. Reservoir-based drug delivery systems utilizing microtechnology. Adv Drug Deliv Rev. 2012;64(14):1590–602. doi:10.1016/j.addr.2012.02.005.
17. Frost M, Meyerhoff ME. In vivo chemical sensors: tackling biocompatibility. Anal Chem. 2006;78(21):7370–7.
18. von Woedtke T, Jülich WD, Hartmann V, Stieber M, Abel PU. Sterilization of enzyme glucose sensors: problems and concepts. Biosens Bioelectron. 2002;17(5):373–82.
19. Klonoff DC. Continuous glucose monitoring. Roadmap for 21st century diabetes therapy. Diabetes Care. 2005;28(5):1231–9.
20. Gadsby R, Snow R, Daly AC, Crowe S, Matyka K, Hall B, et al. Setting research priorities for type 1 diabetes. Diabet Med. 2012;29(10):1321–6. doi:10.1111/j.1464-5491.2012.03755.x.
21. Elleri D, Allen JM, Kumareswaran K, Leelarathna L, Nodale M, Caldwell K, et al. Closed-loop basal insulin delivery over 36 hours in adolescents with type 1 diabetes: randomized clinical trial. Diabetes Care. 2013;36(4):838–44.
22. Shivers JP, Mackowiak L, Anhalt H, Zisser H. “Turn it off!”: diabetes device alarm fatigue considerations for the present and the future. J Diabetes Sci Technol. 2013;7(3):789–94.
23. Sullivan SP, Koutsonanos DG, Martin MP, Lee J-W, Zarnitsyn V, Murthy N, et al. Dissolving polymer microneedle patches for influenza vaccination. Nat Med. 2010;16(8):915–20.
24. Caffarel-Salvador E, Brady AJ, Eltayib E, Meng T, Alonso-Vicente A, Gonzalez-Vazquez P, et al. Hydrogel-forming microneedle arrays allow detection of drugs and glucose in vivo: potential for use in diagnosis and therapeutic drug monitoring. PLoS ONE. 2016;10(12), e0145644. doi:10.1371/journal.pone.0145644.
25. Castle JR, Pitts A, Hanavan K, Muhly R, El Youssef J, Hughes-Karvetski C, et al. The accuracy benefit of multiple amperometric glucose sensors in people with type 1 diabetes. Diabetes Care. 2012;35(4):706–10.